Page last updated: 2024-10-29

iodixanol and Waldenstrom Macroglobulinemia

iodixanol has been researched along with Waldenstrom Macroglobulinemia in 1 studies

iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.

Waldenstrom Macroglobulinemia: A lymphoproliferative disorder characterized by pleomorphic B-LYMPHOCYTES including PLASMA CELLS, with increased levels of monoclonal serum IMMUNOGLOBULIN M. There is lymphoplasmacytic cells infiltration into bone marrow and often other tissues, also known as lymphoplasmacytic lymphoma. Clinical features include ANEMIA; HEMORRHAGES; and hyperviscosity.

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Scarpioni, R	1
Cristinelli, L	1
Quaretti, P	1
Imberti, D	1
Cavallotti, P	1

Other Studies

1 other study available for iodixanol and Waldenstrom Macroglobulinemia

Article	Year
Waldenström's macroglobulinaemia and acute renal failure: isoosmolal non-ionic contrast medium is not an absolute contraindication. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2001, Volume: 16, Issue:5 Topics: Aged; Angiography; Contraindications; Contrast Media; Humans; Kidney Failure, Chronic; Male; Renal A	2001

Article

Year

Waldenström's macroglobulinaemia and acute renal failure: isoosmolal non-ionic contrast medium is not an absolute contraindication.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2001, Volume: 16, Issue:5

Topics: Aged; Angiography; Contraindications; Contrast Media; Humans; Kidney Failure, Chronic; Male; Renal A

2001